Patients with citrin deficiency exhibit a MAS disruption affecting metabolic pathways including glycolysis, gluconeogenesis (GNEO), lipid metabolism and the TCA cycle, resulting in hypoglycemia, dyslipidemia, hepatic steatosis and an energy deficit (43). The gene discussed is SLC25A13; the disease is Hepatic steatosis.